These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37941902)

  • 1. Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status.
    Jiang W; Liu Z; Liu S; Du T
    Front Endocrinol (Lausanne); 2023; 14():1183075. PubMed ID: 37941902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement.
    Zhu Z; Yang N; Fu H; Yuan G; Chen Y; Du T; Zhou X
    Front Endocrinol (Lausanne); 2022; 13():1002099. PubMed ID: 36187115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of hemoglobin A1c variability and the incidence of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and arterial hypertension.
    Gu J; Fan YQ; Zhang JF; Wang CQ
    Hellenic J Cardiol; 2018; 59(2):91-97. PubMed ID: 28818638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
    Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
    Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction.
    Miller A; McNamara J; Hummel SL; Konerman MC; Tincopa MA
    Sci Rep; 2020 Jul; 10(1):12440. PubMed ID: 32709942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.
    Yu C; Wang L; Xue H; Lin H; Li Y; Chan SO
    Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):58-66. PubMed ID: 30274911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus.
    Han X; Zhang X; Liu Z; Fan H; Guo C; Wang H; Gu Y; Zhang T
    J Diabetes; 2024 May; 16(5):e13564. PubMed ID: 38664879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac Structural and Functional Features in Patients With Type 2 Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction:A Study Based on Propensity Score Matching].
    Peng KL; Liu YM; Jia XY; Wang H; Gou CL; Xue LL; Zou Q; Zhang WJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):264-272. PubMed ID: 37157074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
    Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
    Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes.
    Xie Y; Kong W; Wang X; Wu Z
    BMC Endocr Disord; 2022 Aug; 22(1):220. PubMed ID: 36045348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT.
    Peters AE; Pandey A; Ayers C; Wegermann K; McGarrah RW; Grodin JL; Abdelmalek MF; Bekfani T; Blumer V; Diehl AM; Moylan CA; Fudim M
    ESC Heart Fail; 2021 Apr; 8(2):842-848. PubMed ID: 33586354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
    Mantovani A; Taverna A; Cappelli D; Beatrice G; Csermely A; Sani E; Byrne CD; Targher G
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?
    Prausmüller S; Weidenhammer A; Heitzinger G; Spinka G; Goliasch G; Arfsten H; Abdel Mawgoud R; Gabler C; Strunk G; Hengstenberg C; Hülsmann M; Bartko PE; Pavo N
    Eur J Prev Cardiol; 2023 Sep; 30(12):1247-1254. PubMed ID: 37210596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
    Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
    Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Structure and Function in Patients With Obesity and Non-alcoholic Fatty Liver Disease.
    Asatullina Z; Sineglazova AV
    Cureus; 2023 Aug; 15(8):e43711. PubMed ID: 37724205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced liver fibrosis predicts heart failure and hospitalizations in people with type 2 diabetes: A prospective cohort study from Hong Kong Diabetes Register.
    Kong AP; Lau ES; O CK; Luk AO; Yip TC; Chow EY; Kwok R; Lee HW; Wong GL; Ma RC; Chan HL; Wong VW; Chan JC
    Diabetes Res Clin Pract; 2023 Aug; 202():110825. PubMed ID: 37442241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction.
    Liu X; Chen W; Shao W; Jiang Y; Cao Z; He W; Wu M; Chen Z; Ma J; Chen Y; Yu P; Zhang Y; Wang J
    ESC Heart Fail; 2022 Dec; 9(6):3985-3994. PubMed ID: 35996808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.
    Yoshihisa A; Sato Y; Yokokawa T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Saitoh SI; Takeishi Y
    ESC Heart Fail; 2018 Apr; 5(2):262-270. PubMed ID: 28967709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.